These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25827397)

  • 21. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
    Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
    Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileishmanial activity of nano-amphotericin B deoxycholate.
    Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach.
    Manandhar KD; Yadav TP; Prajapati VK; Basukala O; Aganja RP; Dude A; Shrivastav ON; Sundar S
    Adv Exp Med Biol; 2014; 808():77-91. PubMed ID: 24595612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.
    Jain K; Verma AK; Mishra PR; Jain NK
    Nanomedicine; 2015 Apr; 11(3):705-13. PubMed ID: 25596078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic fungicidal effect of low-frequency and low-intensity ultrasound with amphotericin B-loaded nanoparticles on C. albicans in vitro.
    Yang M; Xie S; Adhikari VP; Dong Y; Du Y; Li D
    Int J Pharm; 2018 May; 542(1-2):232-241. PubMed ID: 29559330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.
    Verma RK; Pandya S; Misra A
    J Biomed Nanotechnol; 2011 Feb; 7(1):118-20. PubMed ID: 21485832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system.
    Khan AA; Alanazi AM; Jabeen M; Khan S; Malik A
    Eur J Pharm Sci; 2018 Jul; 119():171-178. PubMed ID: 29653177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
    Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
    Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model.
    Takemoto K; Yamamoto Y; Kanazawa K
    J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Delivery of Amphotericin B through Core-Shell Composite Based on PLGA/Ag/Fe
    Sadat Akhavi S; Moradi Dehaghi S
    Appl Biochem Biotechnol; 2020 Jun; 191(2):496-510. PubMed ID: 31797150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
    Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
    J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
    Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.
    Amaral AC; Marques AF; Muñoz JE; Bocca AL; Simioni AR; Tedesco AC; Morais PC; Travassos LR; Taborda CP; Felipe MS
    Br J Pharmacol; 2010 Mar; 159(5):1126-32. PubMed ID: 20136827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis.
    Souza RO; Henrique de Lima T; Oréfice RL; de Freitas Araújo MG; de Lima Moura SA; Magalhães JT; da Silva GR
    J Pharm Sci; 2018 Oct; 107(10):2674-2685. PubMed ID: 29940181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan.
    Falk R; Hacham M; Nyska A; Foley JF; Domb AJ; Polacheck I
    J Antimicrob Chemother; 2005 May; 55(5):713-20. PubMed ID: 15814605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
    Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuously infused amphotericin B deoxycholate for primary treatment of invasive fungal disease in acute myeloid leukaemia.
    Rothenbühler C; Held U; Manz MG; Schanz U; Gerber B
    Hematol Oncol; 2018 Apr; 36(2):471-480. PubMed ID: 29431860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.